Medicine

In a recent paper, researchers have advocated for equitable and inclusive practices in cannabis research, addressing the historical and ongoing disparities in enforcement and the industry’s profit distribution.

Five years after the United Kingdom legalized medical cannabis products for use on the National Health Service (NHS), the government still has not funded the trials that would allow physicians to prescribe cannabis products.

A recent study found that about 80% of people who consume cannabis to help with sleep quit using prescription and over-the-counter sleep aids such as melatonin and benzodiazepines.

Lawmakers in Japan’s House of Representatives have passed a bill to legalize cannabis-derived pharmaceuticals. The bill would also establish legal restrictions on general cannabis use, which was not previously referenced under federal law.

The medical cannabis market in Ohio is expected to hit $520 million this year, according to cannabis industry intelligence firm BDSA, which also predicts the state’s combined cannabis markets will total $820 million in 2025.

A recent study published in the journal Psychedelic Medicine found that a majority of American Psychiatric Association members either moderately or strongly believed that hallucinogens show promise in treating psychiatric conditions.

A recent study found that the majority of Minnesota medical cannabis patients are enrolled in the program for intractable pain, but older and younger adults received “significant differences in dosages.”

According to a recent survey, 88% of cannabis patients say their use of medical cannabis has reduced their use of prescription drugs, alcohol, or both.

Some Georgia pharmacies have begun selling low-THC medical cannabis oils under the state’s medical cannabis program. The pharmacies are the first in the U.S. to participate in medical cannabis sales.

The Canadian Paediatric Society has released a position statement on medical cannabis treatments for children under 18 years old.

In a first for the country, some independent pharmacies in Georgia are set to soon begin offering low-THC cannabis oils under the state’s limited medical cannabis program.

A bill introduced in Michigan would let students use prescribed medical cannabis while at school. Supporters say it would allow students to take their medicine without interrupting academic time.

The American Nurses Association — which represents the more than 4 million registered nurses in the U.S. — this week announced its formal recognition of cannabis nursing as a nursing specialty.

The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CMAS) has recommended the removal of cannabis from its list of banned substances for all three collegiate divisions.

Texas Agricultural Commissioner Sid Miller (R) said that he believes if medical cannabis reforms were to get a vote in the state legislature, they would be supported by “70% to 80%” of lawmakers because “we have such good science on it.”

Officials on the Ohio State Medical Board last week added irritable bowel syndrome (IBS) as a qualifying condition to the state’s medical cannabis program.

A recent study published in Clinical Therapeutics found that 91% of military veterans who use medical cannabis said it has improved their quality of life.

The Ukraine Parliament gave initial approval this week to a medical cannabis legalization proposal. The law still could see additional amendments and must pass a second reading before heading to President Volodymyr Zelensky for his signature.

The Minnesota Department of Health has added irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying conditions for accessing the state medical cannabis program.

The Pennsylvania Senate Law & Justice Committee advanced a proposal that would let physicians certify patients for the state’s medical cannabis program for any condition they deem appropriate.

A Washington D.C. judge ruled this week that a medical cannabis patient who smokes in his apartment must stop following a neighbor’s complaint that the odor caused a nuisance in her apartment.

Weill Cornell Medicine researchers have received a five-year, $11.6 million grant from the National Institute on Drug Abuse to investigate the effects of cannabis on the brains of people who are living with HIV.

The New Mexico Department of Health has added insomnia to the state’s medical cannabis qualifying conditions list; patients with insomnia will be allowed to enroll starting June 1.